P789: EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN (IPTA) MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH THE ANTI-C5 MONOCLONAL ANTIBODY (MAB) TESIDOLUMAB (TESI)

Detalles Bibliográficos
Autores principales: Ando, Kiyoshi, Griškevičius, Laimonas, Ikezoe, Takayuki, Ito, Yoshikazu, Masuko, Masayoshi, Ueda, Yasutaka, Bagger, Morten, Danekula, Rambabu, Rozenberg, Izabela, Junge, Guido, Mayer, Jiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430731/
http://dx.doi.org/10.1097/01.HS9.0000970060.17022.e8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430731/
http://dx.doi.org/10.1097/01.HS9.0000970060.17022.e8

Ejemplares similares